2. I'm just quoting what you said. That this should still be around .12 WHEN they do reach phase 3 (thats just crazy talk)
3. They have completed 4 phase 2A trials, with success.
4. You seem to be acting like this is a $5 Bio stock. It's not, it's in the early stages and the rock bottom price reflects that.
My point is some of the pre clinicals moving into phase 1s are obvious potential catalyst. It has a super low float and can run hard on any news.
i'm in and holding. OWCP ran to $3 on mostly fluff, this has way more potential and could do the same. Not saying it's worth that, but I could see this running to .50 easy.
Best of luck.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM